Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boulder, Colorado
- Most recent report
- 8-K, filed Nov 4, 2026
- Incorporated
- Delaware
- Filings on record
- 404 filings
- On EDGAR
- CIK 1637715
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 24
News 8 of 55
Prospectuses and Registrations 8 of 38
- 424B5 Prospectus supplement for an offering Aug 4, 2026
- S-8 Registration statement for an employee plan Jun 5, 2026
- S-3 Shelf registration statement Apr 24, 2026
- S-8 Registration statement for an employee plan Mar 12, 2026
- 424B3 Prospectus supplement for an offering Nov 21, 2025
- POS AM Post-effective amendment to a registration Nov 6, 2025
- S-3 Shelf registration statement Nov 6, 2025
- 424B3 Prospectus supplement for an offering Nov 6, 2025
Proxies 8
- DEFA14A Extra proxy material Apr 21, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2026
- DEFA14A Extra proxy material Apr 16, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 16, 2025
- DEFA14A Extra proxy material Apr 26, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2023
- DEFA14A Extra proxy material Apr 22, 2022
- DEF 14A Proxy statement for a shareholder vote Apr 22, 2022
Ownership 8 of 235
- SCHEDULE 13G Large holder reported a passive stake Oct 7, 2026
- 4 Insider reported a trade Sep 23, 2026
- 4 Insider reported a trade Sep 23, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4/A Insider reported a trade, amended Aug 13, 2026
- 4 Insider reported a trade Aug 11, 2026
Other 8 of 44
- EFFECT Notice that a registration became effective May 4, 2026
- CORRESP Reply to SEC staff Apr 30, 2026
- UPLOAD Comment letter from SEC staff Apr 30, 2026
- ARS Annual report sent to shareholders Apr 21, 2026
- EFFECT Notice that a registration became effective Nov 18, 2025
- ARS Annual report sent to shareholders Apr 16, 2025
- EFFECT Notice that a registration became effective Mar 21, 2025
- EFFECT Notice that a registration became effective Oct 30, 2024
Everything here comes from OnKure Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.